RE: Clovis11 Nov 2022 08:34
How can we be competition when TW says we’re in a death spiral and it doesn’t work?
“Examples of companies who are developing FAP-targeted radionuclide therapies include Novartis, POINT Biopharma, Precision Molecular and Philogen S.p.A. Examples of companies who are developing FAP-targeted radionuclides for imaging applications include SOFIE Biosciences, Lantheus and Noria Therapeutics. Companies are also developing FAP-targeted therapies that do not deliver radiation to solid tumors. These companies include Avacta Life Sciences Ltd, Molecular Partners, AG, Amgen, Roche, PSiOxus Therapeutics, Bioxcel Therapeutics, Oncomatryx Biopharma, Umoja Biopharma and Evotec.”